(Total Views: 497)
Posted On: 10/08/2020 10:57:50 AM
Post# of 145254
This is very interesting, I wonder how many trial participants from all indications have other benefits from Leronlimab beyond the trial indication? I would imagine the HIV participants have a wide range of ailments from the side effects of the previous SOC drugs that might be improved after switching to Leronlimab.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)